Pyxis Oncology, Inc. (PYXS) — key financial figures for fiscal year 2025 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2025)

$13.9M

Net Income/Loss (FY2025)

-$79.6M

Total Assets (FY2025)

$91.5M

Total Equity (FY2025)

$53.4M

Cash Flows from Operating Activities (FY2025)

-$63.5M

Source: Pyxis Oncology, Inc. 10-K filing (FY2025). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.